Home > Insider Trading > Filing (0001093557-21-000223)

Filing Details

Accession Number:: 0001093557-21-000223
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-13 20:19:16
Reporting Period:: 2021-09-09

Accepted Time:: 2021-09-13 20:19:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1093557	Dexcom Inc	DXCM	Surgical & Medical Instruments & Apparatus (3841)	330857544

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1323190	K Andrew Balo	6340 Sequence Drive San Diego CA 92121	*	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-09-09	2,498	$0.00	14,056	No	5	J	Direct
Common Stock	Acquisiton	2021-09-09	2,498	$0.00	13,150	No	5	J	Indirect	by Trust
Common Stock	Disposition	2021-09-09	1,248	$541.36	11,902	No	4	S	Indirect	by Trust
Common Stock	Disposition	2021-09-09	15	$541.76	11,887	No	4	S	Indirect	by Trust
Common Stock	Disposition	2021-09-09	273	$541.33	11,614	No	4	S	Indirect	by Trust
Common Stock	Disposition	2021-09-09	200	$542.83	11,414	No	4	S	Indirect	by Trust
Common Stock	Disposition	2021-09-09	50	$543.66	11,364	No	4	S	Indirect	by Trust
Common Stock	Disposition	2021-09-09	550	$547.35	10,814	No	4	S	Indirect	by Trust
Common Stock	Disposition	2021-09-09	750	$548.24	10,064	No	4	S	Indirect	by Trust
Common Stock	Disposition	2021-09-09	1,261	$549.43	8,803	No	4	S	Indirect	by Trust
Common Stock	Disposition	2021-09-09	1,200	$550.36	7,603	No	4	S	Indirect	by Trust
Common Stock	Disposition	2021-09-09	50	$551.45	7,553	No	4	S	Indirect	by Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	J	Direct
No	5	J	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust

Footnotes

Shares were transferred from direct ownership to ownership under the Balo Family Trust upon vesting of previously awarded restricted stock units.
Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022.
Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan.
This transaction was executed in multiple trades at prices ranging from $541.27 to $541.36. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $542.55 to $543.40. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $546.745 to $547.740. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $547.80 to $548.65. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $548.93 to $549.92. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $549.99 to $550.73. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.